Form 4 filings across 30 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$692.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 104 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 35 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.
The 150 most recent Form 4 transactions.
| +$779.6K |
| 70,000 |
| Sep 28 |
| SION | Sionna Therapeutics, Inc. | $0 | $43.3M | -$43.3M | 3.4M | Sep 17 |
| TYRA | Tyra Biosciences, Inc. | $15.3M | $0 | +$15.3M | 10.3M | Sep 15 |
| ARTV | Artiva Biotherapeutics, Inc. | $92.7M | $0 | +$92.7M | 17.3M | Sep 10 |
| SEPN | Septerna, Inc. | $0 | $63.5M | -$63.5M | 725,443 | Aug 12 |
| IKT | Inhibikase Therapeutics, Inc. | $0 | $0 | $0 | 7M | Jul 29 |
| PBLS | Parabilis Medicines, Inc. | $430.7M | $0 | +$430.7M | 26.5M | Jul 22 |
| FRNM | Freenome, Inc. | $0 | $0 | $0 | 1.2M | Jul 20 |
| SPRY | ARS Pharmaceuticals, Inc. | $0 | $0 | $0 | — | Jun 24 |
| PEPG | PepGen Inc. | $30M | $0 | +$30M | 18.6M | Jun 18 |
| HOWL | Werewolf Therapeutics, Inc. | $487.2K | $963.9K | -$476.7K | 303,719 | Jun 17 |
| ACRV | Acrivon Therapeutics, Inc. | $0 | $0 | $0 | 9,366 | Jun 17 |
| COAG | Hemab Therapeutics Holdings, Inc. | $55.5M | $0 | +$55.5M | 6.4M | Jun 16 |
| JANX | Janux Therapeutics, Inc. | $0 | $0 | $0 | 11,750 | Jun 11 |
| NKTX | Nkarta, Inc. | $0 | $0 | $0 | — | Jun 10 |
| BCAX | Bicara Therapeutics Inc. | $4.8M | $0 | +$4.8M | 4.6M | Jun 9 |
| ABOS | Acumen Pharmaceuticals, Inc. | $0 | $0 | $0 | 48,300 | Jun 3 |
| PRLD | Prelude Therapeutics Inc | $0 | $0 | $0 | 6.5M | Apr 27 |
| ACET | Adicet Bio, Inc. | $1.6M | $0 | +$1.6M | 932,624 | Apr 27 |
| MLYS | Mineralys Therapeutics, Inc. | $38.8M | $0 | +$38.8M | 5.8M | Mar 30 |
| EVMN | Evommune, Inc. | $20M | $0 | +$20M | 2.7M | Feb 17 |
| SGP | SpyGlass Pharma, Inc. | $59M | $0 | +$59M | 2.1M | Feb 9 |
| CDTX | Cidara Therapeutics, Inc. | $100M | $0 | +$100M | 0 | Jan 7 |
| FULC | Fulcrum Therapeutics, Inc. | $0 | $58.4M | -$58.4M | 6.1M | Dec 8, 2025 |
| ETNB | 89bio, Inc. | $0 | $0 | $0 | 0 | Oct 30, 2025 |
| JBIO | Jade Biosciences, Inc. | $0 | $0 | $0 | 1.3M | Apr 28, 2025 |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | CCONV◆ | 1.3M | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | CCONV◆ | 2.8M | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | PBUY | 164,891 | $16.00 | $2.6M | +12.4% | Open the original filing on SEC.gov |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | PBUY | 2.3M | $16.00 | $37.4M | +64.9% | Open the original filing on SEC.gov |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | CCONV | 1.3M | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | CCONV | 3.1M | — | — | +693.0% | Open the original filing on SEC.gov |
| Oct 30 | BBTX | Bambusa Therapeutics, Inc. | PBUY | 263,911 | $14.92 | $3.9M | +139.0% | Open the original filing on SEC.gov |
| Oct 30 | BBTX | Bambusa Therapeutics, Inc. | PBUY | 189,909 | $14.23 | $2.7M | — | Open the original filing on SEC.gov |
| Oct 29 | LENZ | LENZ Therapeutics, Inc. | SSELL | 107,170 | $3.36 | $360.1K | -65.1% | Open the original filing on SEC.gov |
| Oct 29 | LENZ | LENZ Therapeutics, Inc. | SSELL | 451,998 | $3.36 | $1.5M | -65.1% | Open the original filing on SEC.gov |
| Oct 29 | LENZ | LENZ Therapeutics, Inc. | SSELL | 2.2M | $3.36 | $7.3M | -65.1% | Open the original filing on SEC.gov |
| Oct 5 | WVE | Wave Life Sciences, Inc. | AGRANT◆ | 64,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 5 | WVE | Wave Life Sciences, Inc. | AGRANT | 10,700 | — | — | +37.1% | Open the original filing on SEC.gov |
| Oct 2 | VOR | Vor Biopharma Inc. | MEXER◆ | 500 | — | — | — | Open the original filing on SEC.gov |
| Oct 2 | VOR | Vor Biopharma Inc. | MEXER | 500 | $12.80 | $6.4K | — | Open the original filing on SEC.gov |
| Sep 28 | CLYM | Climb Bio, Inc. | MEXER◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | CLYM | Climb Bio, Inc. | MEXER◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | CLYM | Climb Bio, Inc. | MEXER◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | CLYM | Climb Bio, Inc. | MEXER◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | CLYM | Climb Bio, Inc. | MEXER | 40,000 | $1.29 | $51.6K | +133.3% | Open the original filing on SEC.gov |
| Sep 28 | CLYM | Climb Bio, Inc. | MEXER | 10,000 | $7.89 | $78.9K | +50.0% | Open the original filing on SEC.gov |
| Sep 28 | CLYM | Climb Bio, Inc. | MEXER | 10,000 | $3.00 | $30K | +100.0% | Open the original filing on SEC.gov |
| Sep 28 | CLYM | Climb Bio, Inc. | MEXER | 10,000 | $3.46 | $34.6K | — | Open the original filing on SEC.gov |
| Sep 17 | SION | Sionna Therapeutics, Inc. | SSELL | 33,800 | $7.46 | $252.1K | -1.0% | Open the original filing on SEC.gov |
| Sep 17 | SION | Sionna Therapeutics, Inc. | SSELL | 3.4M | $6.32 | $21.6M | -49.5% | Open the original filing on SEC.gov |
| Sep 15 | TYRA | Tyra Biosciences, Inc. | PDBUY◆ | 9.1M | $22.03 | $200M | — | Open the original filing on SEC.gov |
| Sep 10 | ARTV | Artiva Biotherapeutics,… | AGRANT◆ | 16,250 | — | — | — | Open the original filing on SEC.gov |
| Sep 8 | ARTV | Artiva Biotherapeutics,… | AGRANT◆ | 13,750 | — | — | — | Open the original filing on SEC.gov |
| Aug 24 | VOR | Vor Biopharma Inc. | MEXER◆ | 1,500 | — | — | — | Open the original filing on SEC.gov |
| Aug 24 | VOR | Vor Biopharma Inc. | MEXER | 1,500 | $3.74 | $5.6K | — | Open the original filing on SEC.gov |
| Aug 12 | SEPN | Septerna, Inc. | SSELL | 746,500 | $42.50 | $31.7M | -50.7% | Open the original filing on SEC.gov |
| Aug 12 | SEPN | Septerna, Inc. | SSELL | 746,500 | $42.50 | $31.7M | -13.5% | Open the original filing on SEC.gov |
| Jul 31 | ARTV | Artiva Biotherapeutics,… | PBUY | 24,944 | $9.93 | $247.7K | +0.1% | Open the original filing on SEC.gov |
| Jul 29 | IKT | Inhibikase Therapeutics,… | JOTHER◆ | 18M | — | — | — | Open the original filing on SEC.gov |
| Jul 29 | IKT | Inhibikase Therapeutics,… | JOTHER | 18M | — | — | -72.1% | Open the original filing on SEC.gov |
| Jul 29 | ARTV | Artiva Biotherapeutics,… | PBUY | 20,824 | $9.99 | $208K | +0.1% | Open the original filing on SEC.gov |
| Jul 24 | ARTV | Artiva Biotherapeutics,… | PBUY | 41,319 | $9.99 | $412.8K | +0.2% | Open the original filing on SEC.gov |
| Jul 23 | ARTV | Artiva Biotherapeutics,… | PBUY | 59,880 | $9.96 | $596.4K | +0.4% | Open the original filing on SEC.gov |
| Jul 22 | PBLS | Parabilis Medicines, Inc. | PBUY | 47,250 | $29.77 | $1.4M | +0.2% | Open the original filing on SEC.gov |
| Jul 22 | ARTV | Artiva Biotherapeutics,… | PBUY | 84,124 | $9.93 | $835.4K | +0.5% | Open the original filing on SEC.gov |
| Jul 21 | PBLS | Parabilis Medicines, Inc. | PBUY | 37,723 | $30.00 | $1.1M | +0.1% | Open the original filing on SEC.gov |
| Jul 21 | PBLS | Parabilis Medicines, Inc. | PBUY | 6,504 | $29.17 | $189.7K | +<0.1% | Open the original filing on SEC.gov |
| Jul 21 | PBLS | Parabilis Medicines, Inc. | PBUY | 21,696 | $27.96 | $606.6K | +<0.1% | Open the original filing on SEC.gov |
| Jul 21 | ARTV | Artiva Biotherapeutics,… | PBUY | 120,582 | $9.55 | $1.2M | +0.7% | Open the original filing on SEC.gov |
| Jul 20 | PBLS | Parabilis Medicines, Inc. | PBUY | 32,987 | $27.72 | $914.4K | +0.1% | Open the original filing on SEC.gov |
| Jul 20 | PBLS | Parabilis Medicines, Inc. | PBUY | 98,433 | $27.13 | $2.7M | +0.4% | Open the original filing on SEC.gov |
| Jul 20 | FRNM | Freenome, Inc. | AGRANT | 336,965 | $10.00 | $3.4M | +37.1% | Open the original filing on SEC.gov |
| Jul 20 | FRNM | Freenome, Inc. | AGRANT | 4.9M | $10.00 | $49.2M | +67.3% | Open the original filing on SEC.gov |
| Jul 20 | FRNM | Freenome, Inc. | AGRANT | 367,427 | — | — | — | Open the original filing on SEC.gov |
| Jul 20 | FRNM | Freenome, Inc. | AGRANT | 908,103 | — | — | — | Open the original filing on SEC.gov |
| Jul 20 | FRNM | Freenome, Inc. | AGRANT | 553,703 | — | — | — | Open the original filing on SEC.gov |
| Jul 20 | FRNM | Freenome, Inc. | AGRANT | 970,950 | — | — | — | Open the original filing on SEC.gov |
| Jul 20 | FRNM | Freenome, Inc. | AGRANT | 6.6M | — | — | +874.9% | Open the original filing on SEC.gov |
| Jul 17 | ARTV | Artiva Biotherapeutics,… | PBUY | 7,882 | $8.95 | $70.5K | +<0.1% | Open the original filing on SEC.gov |
| Jul 16 | ARTV | Artiva Biotherapeutics,… | PBUY | 152,472 | $8.93 | $1.4M | +0.9% | Open the original filing on SEC.gov |
| Jul 16 | VOR | Vor Biopharma Inc. | XXITM◆ | 2.1M | $5.00 | $10.5M | — | Open the original filing on SEC.gov |
| Jul 16 | VOR | Vor Biopharma Inc. | SSELL | 213 | $19.75 | $4.2K | 0.0% | Open the original filing on SEC.gov |
| Jul 16 | VOR | Vor Biopharma Inc. | XXITM | 2.1M | $0.002 | $4.2K | +87.4% | Open the original filing on SEC.gov |
| Jul 13 | ARTV | Artiva Biotherapeutics,… | PBUY | 6,552 | $8.94 | $58.6K | +<0.1% | Open the original filing on SEC.gov |
| Jul 13 | ARTV | Artiva Biotherapeutics,… | PBUY↺ | 6,522 | $8.94 | $58.3K | +<0.1% | Open the original filing on SEC.gov |
| Jul 10 | ARTV | Artiva Biotherapeutics,… | PBUY | 15,102 | $8.97 | $135.5K | +<0.1% | Open the original filing on SEC.gov |
| Jun 29 | CLYM | Climb Bio, Inc. | AGRANT◆ | 70,284 | — | — | — | Open the original filing on SEC.gov |
| Jun 26 | ARTV | Artiva Biotherapeutics,… | PBUY | 1,876 | $8.98 | $16.8K | +<0.1% | Open the original filing on SEC.gov |
| Jun 26 | SEPN | Septerna, Inc. | AGRANT◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25 | ARTV | Artiva Biotherapeutics,… | PBUY | 31,000 | $8.88 | $275.3K | +0.2% | Open the original filing on SEC.gov |
| Jun 24 | SPRY | ARS Pharmaceuticals, Inc. | AGRANT◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | PEPG | PepGen Inc. | AGRANT◆ | 34,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | SION | Sionna Therapeutics, Inc. | AGRANT◆ | 17,340 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | HOWL | Werewolf Therapeutics,… | SSELL | 27,695 | $0.35 | $9.7K | -8.4% | Open the original filing on SEC.gov |
| Jun 17 | HOWL | Werewolf Therapeutics,… | SSELL | 389,216 | $0.35 | $136.2K | -8.4% | Open the original filing on SEC.gov |
| Jun 17 | ACRV | Acrivon Therapeutics, Inc. | AGRANT◆ | 20,275 | — | — | — | Open the original filing on SEC.gov |
| Jun 16 | HOWL | Werewolf Therapeutics,… | SSELL | 9,939 | $0.37 | $3.7K | -2.9% | Open the original filing on SEC.gov |
| Jun 16 | HOWL | Werewolf Therapeutics,… | SSELL | 139,686 | $0.37 | $51.7K | -2.9% | Open the original filing on SEC.gov |
| Jun 16 | ARTV | Artiva Biotherapeutics,… | PBUY | 124,893 | $8.89 | $1.1M | +0.8% | Open the original filing on SEC.gov |
| Jun 16 | COAG | Hemab Therapeutics… | PBUY | 61,523 | $24.98 | $1.5M | +1.0% | Open the original filing on SEC.gov |
| Jun 15 | LENZ | LENZ Therapeutics, Inc. | AGRANT◆ | 22,100 | — | — | — | Open the original filing on SEC.gov |
| Jun 15 | HOWL | Werewolf Therapeutics,… | SSELL | 8,554 | $0.39 | $3.3K | -2.4% | Open the original filing on SEC.gov |
| Jun 15 | HOWL | Werewolf Therapeutics,… | SSELL | 120,216 | $0.39 | $46.9K | -2.4% | Open the original filing on SEC.gov |
| Jun 15 | ARTV | Artiva Biotherapeutics,… | PBUY | 15,414 | $8.99 | $138.6K | +<0.1% | Open the original filing on SEC.gov |
| Jun 15 | COAG | Hemab Therapeutics… | PBUY | 6,146 | $24.89 | $153K | +0.1% | Open the original filing on SEC.gov |
| Jun 12 | HOWL | Werewolf Therapeutics,… | SSELL | 11,322 | $0.4 | $4.5K | -3.1% | Open the original filing on SEC.gov |
| Jun 12 | HOWL | Werewolf Therapeutics,… | SSELL | 159,119 | $0.4 | $63.6K | -3.1% | Open the original filing on SEC.gov |
| Jun 12 | ARTV | Artiva Biotherapeutics,… | PBUY | 391,019 | $8.57 | $3.4M | +2.4% | Open the original filing on SEC.gov |
| Jun 11 | HOWL | Werewolf Therapeutics,… | SSELL | 17,437 | $0.38 | $6.6K | -4.6% | Open the original filing on SEC.gov |
| Jun 11 | HOWL | Werewolf Therapeutics,… | SSELL | 245,066 | $0.38 | $93.1K | -4.6% | Open the original filing on SEC.gov |
| Jun 11 | ARTV | Artiva Biotherapeutics,… | PBUY | 548,580 | $7.91 | $4.3M | +3.5% | Open the original filing on SEC.gov |
| Jun 11 | VOR | Vor Biopharma Inc. | AGRANT◆ | 57,162 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | JANX | Janux Therapeutics, Inc. | AGRANT◆ | 15,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | JANX | Janux Therapeutics, Inc. | AGRANT | 5,500 | — | — | +88.0% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 1.7M | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 9.4M | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 160,562 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 642,250 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | PBUY | 1.5M | $20.00 | $29.2M | +122.9% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | PBUY | 19.7M | $20.00 | $394.6M | +300.9% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 1.2M | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 6.6M | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | HOWL | Werewolf Therapeutics,… | SSELL | 3,051 | $0.37 | $1.1K | -0.8% | Open the original filing on SEC.gov |
| Jun 10 | HOWL | Werewolf Therapeutics,… | SSELL | 42,872 | $0.37 | $15.9K | -0.8% | Open the original filing on SEC.gov |
| Jun 10 | NKTX | Nkarta, Inc. | AGRANT◆ | 37,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | ARTV | Artiva Biotherapeutics,… | PBUY | 103 | $7.00 | $721 | 0.0% | Open the original filing on SEC.gov |
| Jun 9 | BCAX | Bicara Therapeutics Inc. | AGRANT◆ | 19,475 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | HOWL | Werewolf Therapeutics,… | SSELL | 24,565 | $0.37 | $9.1K | -6.0% | Open the original filing on SEC.gov |
| Jun 9 | HOWL | Werewolf Therapeutics,… | SSELL | 345,235 | $0.37 | $127.7K | -6.0% | Open the original filing on SEC.gov |
| Jun 9 | PBLS | Parabilis Medicines, Inc. | AGRANT◆ | 20,215 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | ARTV | Artiva Biotherapeutics,… | PBUY | 479,039 | $6.91 | $3.3M | +3.1% | Open the original filing on SEC.gov |
| Jun 5 | CLYM | Climb Bio, Inc. | AGRANT◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | ABOS | Acumen Pharmaceuticals,… | AGRANT◆ | 53,250 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | ABOS | Acumen Pharmaceuticals,… | AGRANT | 35,500 | — | — | +277.3% | Open the original filing on SEC.gov |
| May 28 | TYRA | Tyra Biosciences, Inc. | AGRANT◆ | 13,160 | — | — | — | Open the original filing on SEC.gov |
| May 20 | COAG | Hemab Therapeutics… | PBUY | 996 | $24.94 | $24.8K | +<0.1% | Open the original filing on SEC.gov |
| May 19 | COAG | Hemab Therapeutics… | PBUY | 3,802 | $24.97 | $94.9K | +<0.1% | Open the original filing on SEC.gov |
| May 18 | ACRV | Acrivon Therapeutics, Inc. | AGRANT | 9,366 | — | — | — | Open the original filing on SEC.gov |
| May 12 | HOWL | Werewolf Therapeutics,… | SSELL | 6,719 | $0.64 | $4.3K | -1.6% | Open the original filing on SEC.gov |
| May 12 | HOWL | Werewolf Therapeutics,… | SSELL | 94,432 | $0.64 | $60.4K | -1.6% | Open the original filing on SEC.gov |
| May 12 | COAG | Hemab Therapeutics… | PBUY | 6,387 | $24.90 | $159K | +0.1% | Open the original filing on SEC.gov |
| May 11 | COAG | Hemab Therapeutics… | PBUY | 25,720 | $25.00 | $643K | +0.4% | Open the original filing on SEC.gov |
| May 11 | COAG | Hemab Therapeutics… | PBUY | 14,149 | $24.47 | $346.2K | +0.2% | Open the original filing on SEC.gov |
| May 11 | HOWL | Werewolf Therapeutics,… | SSELL | 5,812 | $0.67 | $3.9K | -1.4% | Open the original filing on SEC.gov |
| May 11 | HOWL | Werewolf Therapeutics,… | SSELL | 81,678 | $0.67 | $54.7K | -1.4% | Open the original filing on SEC.gov |
| May 11 | ARTV | Artiva Biotherapeutics,… | PDBUY◆ | 2.2M | $11.52 | $25M | — | Open the original filing on SEC.gov |
| May 11 | ARTV | Artiva Biotherapeutics,… | PBUY | 6.5M | $11.52 | $75M | +74.9% | Open the original filing on SEC.gov |
| May 8 | COAG | Hemab Therapeutics… | PBUY | 1,483 | $24.98 | $37K | +<0.1% | Open the original filing on SEC.gov |
| May 8 | HOWL | Werewolf Therapeutics,… | SSELL | 25,012 | $0.71 | $17.8K | -5.6% | Open the original filing on SEC.gov |
| May 8 | HOWL | Werewolf Therapeutics,… | SSELL | 351,514 | $0.71 | $249.6K | -5.6% | Open the original filing on SEC.gov |
| May 7 | COAG | Hemab Therapeutics… | PBUY | 1,985 | $24.95 | $49.5K | +<0.1% | Open the original filing on SEC.gov |
| May 7 | COAG | Hemab Therapeutics… | PBUY | 7,921 | $24.34 | $192.8K | +0.1% | Open the original filing on SEC.gov |
| May 6 | COAG | Hemab Therapeutics… | PBUY | 53,407 | $24.83 | $1.3M | +0.9% | Open the original filing on SEC.gov |
| May 6 | COAG | Hemab Therapeutics… | PBUY | 14,611 | $23.77 | $347.3K | +0.2% | Open the original filing on SEC.gov |
| May 5 | COAG | Hemab Therapeutics… | PBUY | 10,268 | $25.00 | $256.7K | +0.2% | Open the original filing on SEC.gov |
| May 5 | COAG | Hemab Therapeutics… | PBUY | 87,143 | $24.59 | $2.1M | +1.4% | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV◆ | 10,054 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV◆ | 56,972 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV◆ | 18,146 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV◆ | 42,341 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV◆ | 27,720 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV◆ | 64,680 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | PBUY | 133,750 | $18.00 | $2.4M | +60.5% | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | PBUY | 2.5M | $18.00 | $45.7M | +70.4% | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV | 221,188 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV | 1M | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV | 3.6M | — | — | — | Open the original filing on SEC.gov |
| Apr 29 | CLYM | Climb Bio, Inc. | AGRANT◆ | 2.1M | $9.50 | $20M | — | Open the original filing on SEC.gov |
| Apr 27 | PRLD | Prelude Therapeutics Inc | JOTHER◆ | 1.4M | — | — | — | Open the original filing on SEC.gov |
| Apr 27 | PRLD | Prelude Therapeutics Inc | JOTHER | 1.4M | — | — | -17.8% | Open the original filing on SEC.gov |
| Apr 27 | ACET | Adicet Bio, Inc. | JOTHER◆ | 250,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 27 | ACET | Adicet Bio, Inc. | JOTHER | 250,000 | — | — | -21.1% | Open the original filing on SEC.gov |
| Apr 22 | ACRV | Acrivon Therapeutics, Inc. | AGRANT | 3.9M | $1.80 | $7M | +49.1% | Open the original filing on SEC.gov |